Skip to main content
Fig. 3 | Molecular Cancer

Fig. 3

From: Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer

Fig. 3

Technologies for CTC and ctDNA enrichment, detection and clinical application. A CTCs are preliminary enriched from whole blood sample via different enrichment techniques. Different detection technologies can help with early detection, prognostication, chemotherapy, target therapy of CRC patients. B ctDNA are detected from whole blood sample via targeted and untargeted approaches. ctDNA can supported with early diagnosis, prognosis, disease monitoring and detected the gene mutations of CRC patients. C Exosomes are enriched from whole blood sample via different enrichment techniques. Different detection technologies can help with diagnosis, prognosis, disease monitoring, therapy of CRC patients. D TEPs are detected from whole blood sample via different approaches. TEPs can supported with early cancer detection, diagnosis, and disease monitoring of CRC patients. E CTECs are detected via different approaches. CTECs can supported with early cancer detection, diagnosis and prognosis, antiangiogenic therapy of CRC patients

Back to article page

Molecular Cancer

ISSN: 1476-4598